Share

    


Home / Search Results

Search Results

You searched for:

A deep dive into 4 topics discussed during a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit: business and artificial intelligence technology, research and clinical trials, and precision medicine.
Listed are my highlights of the ASCO 2020 abstracts, which were chosen if they were a practice-changing study or trial with important new advances.
In Louisiana, cancer incidence and death rates are greater than the national average. However, access to early phase clinical trials was nearly impossible to find. 2018 ACCC Innovator Award winner Ochsner Health System partnered with the Translational Genomics Research institute to establish a dedicated center to that accelerated treatment development and expanded patient access to precision …
In the Department of Pharmacy at the University of North Carolina North Carolina Cancer Hospital, discarding partial drug vials was a significant source of waste. With their Innovator Award–winning drug vial optimization program, the program maximized the lifespan of drugs within single-dose vials and realized an annual cost savings of more than $40 million.
CRISPR, a gene editing tool, has entered the scientific arena and public discourse at an astounding speed. Eric B. Kmiec, PhD, director of the Gene Editing Institute at the Helen F. Graham Cancer Center & Research Institute, discusses the emergence of gene editing, how it can be utilized as a tool in the battle against cancer, and the challenges facing its transition from bench to bedside.
Sometimes referred to as the “terminator,” glioblastoma (GBM) is one of the deadliest forms of brain cancer.
Extending precision cancer clinical trials to community cancer programs is a primary goal of the Oncology Research Information Exchange Network (ORIEN), a partnership of some of the leading NCI-designated Cancer Centers nationwide.